Search Results - Disclosure Quest

Type of Offering:

Amount To Be Raised: to

Filing Date: to

Type Of Security:

Industry:

CIK Number:

Principal Place Of Business:

Found 5 results

←

Page 1 of 1

→

Name	Type of Offering	Accepted Date
Resilience Therapeutics, Inc. See All Filings	D	2015-01-21
Amount To Be Raised $3,000,000 Associated Brokers / Dealers N/A CIK Number 0001630938 Filed Document 0001630938-15-000001 Exclusions or Exemptions 506b Accepted Date 2015-01-21 Type of Offering D Industry Pharmaceuticals Offering Tier N/A Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
Resilience Therapeutics, Inc. See All Filings	D/A	2015-03-09
Amount To Be Raised $3,000,000 Associated Brokers / Dealers N/A CIK Number 0001630938 Filed Document 0001630938-15-000002 Exclusions or Exemptions 506b Accepted Date 2015-03-09 Type of Offering D/A Industry Pharmaceuticals Offering Tier N/A Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
Resilience Therapeutics, Inc. See All Filings	D/A	2015-07-30
Amount To Be Raised $3,000,000 Associated Brokers / Dealers N/A CIK Number 0001630938 Filed Document 0001630938-15-000004 Exclusions or Exemptions 506b Accepted Date 2015-07-30 Type of Offering D/A Industry Pharmaceuticals Offering Tier N/A Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
Resilience Therapeutics, Inc. See All Filings	D/A	2015-06-30
Amount To Be Raised $3,000,000 Associated Brokers / Dealers N/A CIK Number 0001630938 Filed Document 0001630938-15-000003 Exclusions or Exemptions 506b Accepted Date 2015-06-30 Type of Offering D/A Industry Pharmaceuticals Offering Tier N/A Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
Resilience Therapeutics, Inc. See All Filings	D	2016-03-03
Amount To Be Raised $10,000,000 Associated Brokers / Dealers N/A CIK Number 0001630938 Filed Document 0001630938-16-000005 Exclusions or Exemptions 506b Accepted Date 2016-03-03 Type of Offering D Industry Pharmaceuticals Offering Tier N/A Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Debt

←

Page 1 of 1

→